Conference abstract · 28 Sep 2015
Conference abstractPublished 2018
Cancerous immunoglobulins and potential clinical applications
University of British Columbia, Canada National Taiwan University Hosepital, Taiwan OncoLock Co.Ltd, Taiwan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Despite the known fact that immunoglobulins are expressed among cancer cells, their roles in cancer immunology are still not fully understood. In 1987, a monoclonal antibody, RP215 was generated and later shown to recognize mainly a carbohydrate-associated (O-glycan) epitope located in the variable regions of heavy chain immunoglobulins (designated in general as CA215) expressed on the surface of cancer cells, but not those from normal B cells. Biological and immunological studies of cancerous immunoglobulins have been performed extensively with RP215 as the unique probe. Both anti-immunoglobulins and RP215 were shown to induce apoptosis and complement-dependent cytotoxicity reactions to culturing cancer cells. In vivo nude mouse animal models also revealed dose-dependent reductions of implanted tumor upon injections of RP215. Gene regulation studies were performed by using semi-quantitative PCR with genes involved in immunoglobulins expressions and toll-like receptors. The binding of RP215 and anti-immunoglobulins to cancer cells was shown to affect similar levels of gene expressions with excellent mutual correlations (R2 ≥ 0.90). Human serum proteins which interact with affinity-purified CA215 and/or cancerous immunoglobulins were identified and found to consist of those with known pro-cancer or anticancer properties. These observations led to the hypothesis of dual functional roles of cancerous immunoglobulins in cancer cells. Interactions with relevant human serum proteins may be essential for proliferation/growth of cancer cells and may also be required to neutralize those hostile to cancer cells. In addition, RP215-based enzyme immunoassay kits are beneficial in monitoring serum levels of CA215 or cancerous immunoglobulins among cancer patients. Anticancer and pan-cancer nature of CA215 revealed that RP215 can be an ideal candidate for the development of anti-cancer drugs or therapeutic treatments. RP215- linked chimeric antigen receptor (CAR)-T cell therapy technology has been attempted for anti-cancer treatments, through a series of CAR construction and validations by cytotoxic cell killing and cytokine activity release assays. In conclusion, dual distinct functional roles of widespread cancerous immunoglobulins among cancer cells have been demonstrated for the potential applications of RP215 in therapeutic treatments of many human cancers.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 22 Jan 2021
Clinical applications of immunoglobulin expression in acute myeloid leukemia
Review article · 28 Jul 2023
Exploring Alternative Cancer Medicines: A Comprehensive Review of Efficacy, Safety, and Potential Clinical Applications
Conference abstract · 25 Jul 2019
Liquid biopsies: A multitude of potential clinical applications for cancer patients
Conference abstract · 26 Oct 2015
Potential clinical application of PG2 (Astragalus polysaccharide) in cancer-related fatigue and immune modulation
More from this journal
The newest in Journal of Clinical & Experimental Oncology.
Review article · 3 Jul 2025
Efficacy of interventions for newly diagnosed multiple myeloma: An umbrella review
Research article · 10 Apr 2025
Multitargets and Interactions of Wortmannin with MSC-Mitogenic Proteins Validate the Enhanced Antiproliferative Effect of MSCSecretome on Breast Cancer Michigan Cancer Foundation-7 Cells
Mini review · 24 Jan 2025
Fractal Analysis in Medical Images
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Oncology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Gregory Lee”
- BylineArticles whose byline prints “Song-Nan Chow”
- BylineArticles whose byline prints “Chin-Hsiang Chien”

